DEGS1 and gastric cancer: While SKI-II is considered a selective inhibitor of SK1 [65], it also inhibits sphingosine kinase 2 and has been shown to have off-target effects on ceramide dihydroceramide desaturase 1 (Des1), leading to reduced S1P accumulation in gastric cancer cells [66].